The popularity of artificial intelligence (AI) technology has been growing exponentially as more uses are explored and AI becomes a typical part of our lives, showcasing itself in both expected and unexpected places, such as fintech, smartphones, self-driving cars, and even the healthcare industry. There are multiple ways AI can be incorporated into the healthcare realm with potentially life-saving impacts. There are two main ways AI can be integrated into better healthcare solutions: drugs can be created that pinpoint particular mutations or people can be tested in advance to see if they have a particular mutation and eventually methods to combat reproduction of mutation can be created before disease even starts to spread.
Multiple cancer drugs and screening tests have been created as more companies adapt AI to healthcare. Recently, we partnered with KST Medical Group in order to adapt our algorithm to predicting cardiovascular disease in patients given their medical history, which will allow those susceptible to take more precautions. Eventually the algorithm will be able to predict the likelihood of cardiovascular events such as heart attacks. To learn more about our plans to venture into healthcare as well as what other companies are doing:Read More.
BOOM Booms By Over 80% In 3 Months As Predicted DMC Global Inc. (NASDAQ: BOOM) is a technology company that operates a variety of businesses in energy, industrial and infrastructure markets. On April 26th, the company released their financial reports for the first quarter. DMC crushed expectations and their stock price soared. Some notable achievements from this quarter were revenue increasing by 72.77%, Cash sky rocketing by 113.0%, and EPS increasing to 0.26, more than double estimates. The company thanked investments and strong execution by the operating team for the strong financial.
The company also has high hopes for the future. YCharts estimates Q2 2018 revenue will increase nearly 1000% from the year before to $0.435. Additionally, the company's growth rate is 20% which shows solid prospects for the upcoming quarter. On April 9th, the I Know First Algorithm gave a bullish 3 month forecast on DMC Global Inc. with a signal of 52.73 and a predictability of 0.48. In agreement with the forecast, BOOM has returned 80.54% over the predicted 3 month period, demonstrating the accuracy of the I Know First Algorithm:Read more.
5 Most Lucrative Israeli Fintech Firms Israel currently has over 7,000 thousand startups, living up to its reputation as the “startup nation.” Israel is considered the most venture capital intense country, with the highest investment funds per capita in the world. Israel’s unique combination of innovative and entrepreneurial mentality, technology-oriented ecosystem, government support, and international investment has driven the proliferation of the startup environment.
The Israeli Fintech market can be categorized into three market segments: digital payment, business finance, and personal finance. Israeli culture and mentality is the most dominant factor in the proliferation of Fintech startups. Israeli mentality is characterized by entrepreneurial spirit and innovative thinking. Moreover, Israeli culture is geared towards ambition and agility due to the underlying immigrant society. To promote technological innovation and exchange novel insights, the Israeli community is enthusiastic towards various networking opportunities, including hubs, conferences, and symposiums. To learn which startups we deemed the 5 most lucrative fintech firms and find out more about them: Read more.
Biogen Inc. Skyrockets As New Drug Brings Hope For Alzheimer's Patients For years, Alzheimer’s researchers have attempted to identify the cause of the neurodegenerative disease to no avail. However, over the past few years, a new hypothesis has gained popularity: amyloid beta and plaque could be the cause of the disease. Yet, this hypothesis is yet to be proven and as more and more drugs targeting amyloid plaque failed, researchers started to doubt whether beta-amyloids were the cause of the disease. However, recently Biogen announced that in phase 2, over 18 months, BAN-2401 showed statistically significant results in Alzheimer’s patients while reducing amyloid plaque. This is not only a success for the drug itself, but the beta-amyloid Alzheimer's hypothesis.
This announcement also had other beneficial implications for Biogen; the company has another drug, Aducanumab, which is also used to target beta-amyloid production. This antibody works by binding with amyloid plaque which prevents the plaque from affecting brain synapses. Right now there are few Alzheimer’s drugs on the market and even so, these drugs do not target the cause of the disease, but rather the symptoms of it. Additionally, these drugs are not even that effective in easing the struggles associated with Alzheimer’s. Therefore, there is a large gap in the market for a truly effective drug to combat the neurodegenerative disease. This is a billion dollar market, therefore, if Biogen's drugs are successful they could reap major rewards:Read more.
I Know First employs a variety of trading strategies to maximize growth. One of these is utilizing I Know First's ETF forecasts for trading. ETF forecasts are generated by using a weighted aggregation of stock-level forecasts and its performance is tested by comparing it a the SPY benchmark.
Once we constructed our portfolio, we found the algorithmically enhanced portfolio had total returns of 45% and 41% versus the benchmark’s 35% as well as Sharpe Ratios of 1.44 and 1.73 versus the benchmark’s 1.05. To learn more about how we obtained these impressive results: Read More.
I am so excited to announce that myself and my co-founder Dr. Lipa Roitman have been invited to speak the 2018 AI In Finance Summit in New York City on September 6-7, 2018. At the conference, we will discuss how I Know First implements artificial intelligence to identify market opportunities and the positive impact AI can have. We are excited to be able to discuss the positive effects of integrating AI and finance, listen to other phenomenal speakers, and connect with other industry leaders.
We will be joined at the conference by 30 other speakers and over 200 attendees. All of the speakers are extremely well versed on the financial world and AI's importance in this realm and we look forward to discussing our ideas with them. Some of the other speakers include directors, vice presdients, AI experts, and more who work at a smorgasbord of places such as the SEC, Mastercard, MIT-Watson AI lab, etc.
The AI In Finance Summit is being sponsored by RE:WORK, a company that focuses on organizing events to connect various industry leaders and members to discuss the future impacts of technology in different sectors. We are honored to have been selected to speak and we are excited for the summit.
Warmest Regards, Yaron Golgher, Co-Founder and CEO
The US employment data released last Friday showed optimism in the United States economy. There were 213,000 jobs added in June, down from the May’s figure of 244,000, but beating the forecast of 195,000 from Thomson Reuters survey. Even though jobs fell slightly short of expectations, the wage growth held steady from the previous month, achieving a year-over-year growth of 2.7% and a monthly increase of 0.2%. However, the rise in the labor force participation drove the unemployment rate up to 4% and Average Hourly Earnings missed the estimates given the country’s strong inflation prospect.
The trade battle is officially underway as the US’s tariffs on $34 billion imports from China and Chinese retaliations took effect on Friday. Market concerns about the trade war may impact the companies’ investment and operations, which probably would go against Trump’s initiative to protect domestic manufacturers. The US dollar pulled back against all of its major counterparts with the DXY dropping down to 93.81 on Monday and is trading below 94.00 since the start of this week.
Supported by strong employment data and weak demand of Yen, the US dollar rose to near a six-month high of 111.355 against Japanese yen on Tuesday until an additional 10% on $200 billion Chinese goods were unveiled and the risk-off sentiment underpinned the Yen’s safe-haven appeal. The pair then dropped and closed at 110.85 on Tuesday. The Bank of Japan remains optimistic that “Japan’s economy is expected to continue expanding moderately” based on the positive outlook of Japanese exports and confidence on inflation reaching to the target level. On the US side, the upcoming CPI figure will possibly prompt the Fed to speed up its plans and raise interest rates.
APPLE STOCK NEWS
Apple News: Apple Quietly Rolls Out New MacBook Pros July 15 |Read More
Apple News: Google's Former Head Of Machine Learning Goes To AAPL July 11 | Read More
Apple News: Apple Music Surpasses Streaming Giant Spotify July 8 | Read More
Apple News: Apple Aims To Better iPhone Performance & Price July 4 | Read More
Apple News: Upcoming Product Updates Build on Predecessors July 1 | Read More
Apple News: iOS 12 Beta Brings Helpful And Fun Features June 27 | Read More
A couple months ago, John Giannandrea, the former head of Google’s search and artificial intelligence division, joined Apple. Reporting directly to Tim Cook, Apple stated that they wanted John to run Apple’s “machine learning and A.I. strategy”. The company is confident in his ability to utilize AI while keeping customers privacy intact. John’s position with Apple is Chief of Machine Learning and AI strategy.
This is a big win for Apple because they are currently lacking in the AI industry which is mainly due to their protection of privacy causing limitations on data collection. Compared to competitors, such as Facebook and Google, Apple is leagues behind in development. John could provide great potential for the growth of Siri and other machine learning technology.
